Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 22.0218.3016.1727.996.60

What is the latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS is 22.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202522.02
Mar202418.30
Mar202316.17
Mar202227.99
Mar20216.60

How is EV/Core EBITDA of JAGSONPAL PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 22.02
20.33
Mar2024 18.3
13.17
Mar2023 16.17
-42.23
Mar2022 27.99
324.09
Mar2021 6.6 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,294.3 Cr -2.8% -4.5% -22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,086.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹169,616.0 Cr -1.9% -1.6% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,361.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹120,713.0 Cr -1.2% -2% 2% Stock Analytics
DR REDDYS LABORATORIES ₹105,881.0 Cr -1.2% 1.5% -6.1% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

-2.8%

-4.5%

-22.2%

SENSEX

-0.3%

-1.1%

7.8%


You may also like the below Video Courses